Evaluation of Effaclar Duo+M on Acne Lesions in Subjects With Mild to Moderate Acne on Face and Trunk

Launched by COSMETIQUE ACTIVE INTERNATIONAL · Jun 14, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how effective a skincare product called Effaclar Duo+M is in treating mild to moderate acne on the face and trunk. The study will last for six months and will track changes in the number of acne lesions, as well as any pigmented spots or scars that participants may have. The goal is to see if this product can help improve the skin condition for those who have acne.

To participate in this study, individuals must be between the ages of 18 and 65 and have mild to moderate acne on their face or trunk. However, people who have other skin problems in the same areas or who have recently used certain treatments that could affect the results won't be eligible. Participants can expect regular assessments of their skin condition over the study period, and they will be using the Effaclar products as part of the trial. This is a great opportunity for those looking for effective acne treatment while helping researchers learn more about these products.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • phototype I to VI
• • mild to moderate acne on the face and trunk
• Exclusion Criteria:
• • cutaneous pathology on the studied zone other than acne
• • topical or systemic treatment during the previous weeks liable to interfere with the assessment of the acceptability and efficacy of the studied products